Lisinopril 1 mg/mL oral suspension

Concentration

1 mg/mL

Batch

200 mL

From

10 × 20 mg tablets

Vehicles named

Ora-Sweet SF, Purified water, Sodium citrate and citric acid oral solution

Container

polyethylene terephthalate (PET) bottle

The label's instructions

Preparation of Suspension (for 200 mL of a 1.0 mg/mL suspension): Add 10 mL of Purified Water USP to a polyethylene terephthalate (PET) bottle containing ten 20 mg tablets of lisinopril and shake for at least one minute. Add 30 mL of Bicitra ®† diluent and 160 mL of Ora-Sweet SF™ †† to the concentrate in the PET bottle and gently shake for several seconds to disperse the ingredients. The suspension should be stored at or below 25°C (77°F) and can be stored for up to four weeks. Shake the suspension before each use. † Registered trademark of Alza Corporation †† Trademark of Paddock Laboratories, Inc.

Quoted verbatim from the Dosage and Administration section of the FDA label for lisinopril, version 4, effective 2021-08-10. Open the label on DailyMed.

Storage and beyond-use date

• “The suspension should be stored at or below 25°C (77°F) and can be stored for up to four weeks.”

Only the storage conditions the source covers are listed. Use the BUD assistant for other cases. The BUD may not be later than any component's expiration date. Verify against the current official USP chapter.

Ingredient checks

No FDA compounding list or NIOSH flags for the active ingredient.

Source

FDA label (lisinopril), Dosage and Administration.

For licensed clinicians. Use with clinical judgment.